Income Statement Orthocell Limited
Equities
OCC
AU000000OCC6
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9900 AUD | -1.00% |
|
-6.60% | -8.76% |
| 19/01 | Orthocell posts quarterly revenue of A$3.2 million | RE |
| 16/01 | Orthocell Finalizes Agreement With Biotechnology Company | MT |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 10.18L | 15.32L | 42.43L | 53.15L | 75.51L | |||||
Total Revenues | 10.18L | 15.32L | 42.43L | 53.15L | 75.51L | |||||
Cost of Goods Sold, Total | 6L | 7L | 10.26L | 16.27L | 27.46L | |||||
Gross Profit | 4L | 8L | 32.17L | 36.88L | 48.05L | |||||
Selling General & Admin Expenses, Total | 47.18L | 55.35L | 59.59L | 66.95L | 94.14L | |||||
R&D Expenses | 73.43L | 68.18L | 75.98L | 86.74L | 88.19L | |||||
Other Operating Expenses | -38.18T | -2.82T | -60.49T | -4L | -4L | |||||
Other Operating Expenses, Total | 1.2Cr | 1.24Cr | 1.35Cr | 1.5Cr | 1.79Cr | |||||
Operating Income | -1.16Cr | -1.15Cr | -1.03Cr | -1.13Cr | -1.31Cr | |||||
Interest And Investment Income | 2L | 84.13T | 9L | 10.32L | 13.01L | |||||
Net Interest Expenses | 2L | 84.13T | 9L | 10.32L | 13.01L | |||||
Currency Exchange Gains (Loss) | 447 | 2L | 18.71T | - | 19.27T | |||||
EBT, Excl. Unusual Items | -1.14Cr | -1.13Cr | -94.11L | -1.02Cr | -1.18Cr | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | -1.14Cr | -1.13Cr | -94.11L | -1.02Cr | -1.18Cr | |||||
Income Tax Expense | -23.94L | -21.44L | -31.62L | -30.51L | -31.85L | |||||
Earnings From Continuing Operations | -90.37L | -91.07L | -62.48L | -71.81L | -85.67L | |||||
Net Income to Company | -90.37L | -91.07L | -62.48L | -71.81L | -85.67L | |||||
Net Income - (IS) | -90.37L | -91.07L | -62.48L | -71.81L | -85.67L | |||||
Net Income to Common Incl Extra Items | -90.37L | -91.07L | -62.48L | -71.81L | -85.67L | |||||
Net Income to Common Excl. Extra Items | -90.37L | -91.07L | -62.48L | -71.81L | -85.67L | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0.05 | -0.05 | -0.03 | -0.04 | -0.04 | |||||
Basic EPS - Continuing Operations | -0.05 | -0.05 | -0.03 | -0.04 | -0.04 | |||||
Basic Weighted Average Shares Outstanding | 19Cr | 19Cr | 20Cr | 20Cr | 22Cr | |||||
Net EPS - Diluted | -0.05 | -0.05 | -0.03 | -0.04 | -0.04 | |||||
Diluted EPS - Continuing Operations | -0.05 | -0.05 | -0.03 | -0.04 | -0.04 | |||||
Diluted Weighted Average Shares Outstanding | 19Cr | 19Cr | 20Cr | 20Cr | 22Cr | |||||
Normalized Basic EPS | -0.04 | -0.04 | -0.03 | -0.03 | -0.03 | |||||
Normalized Diluted EPS | -0.04 | -0.04 | -0.03 | -0.03 | -0.03 | |||||
Supplemental Items | ||||||||||
EBITDA | -1.13Cr | -1.13Cr | -99.25L | -1.09Cr | -1.27Cr | |||||
EBITA | -1.14Cr | -1.14Cr | -1.02Cr | -1.12Cr | -1.3Cr | |||||
EBIT | -1.16Cr | -1.15Cr | -1.03Cr | -1.13Cr | -1.31Cr | |||||
EBITDAR | -1.13Cr | -1.13Cr | -99.22L | -1.09Cr | -1.27Cr | |||||
Effective Tax Rate - (Ratio) | 20.95 | 19.06 | 33.6 | 29.82 | 27.1 | |||||
Current Domestic Taxes | - | - | - | - | - | |||||
Total Current Taxes | -23.94L | -21.44L | -31.62L | -30.51L | -31.85L | |||||
Normalized Net Income | -71.45L | -70.32L | -58.82L | -63.95L | -73.45L | |||||
Interest on Long-Term Debt | 15.27T | 20.87T | 30.57T | 60.52T | 52.55T | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 14.65L | 32.98L | 17.09L | 30.85L | 54.61L | |||||
General and Administrative Expenses | 32.54L | 22.37L | 42.5L | 36.1L | 39.53L | |||||
Research And Development Expense From Footnotes | 73.43L | 68.18L | 75.98L | 86.74L | 88.19L | |||||
Net Rental Expense, Total | 2.55T | 2.55T | 2.91T | 2.94T | 2.94T | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 42.99L | 5L | 24.92L | 20.96L | 15.4L | |||||
Total Stock-Based Compensation | 42.99L | 5L | 24.92L | 20.96L | 15.4L |
- Stock Market
- Equities
- OCC Stock
- Financials Orthocell Limited
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















